Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study

被引:249
作者
Doern, GV [1 ]
Brueggemann, AB [1 ]
Pierce, G [1 ]
Holley, HP [1 ]
Rauch, A [1 ]
机构
[1] GLAXO WELLCOME INC,MED AFFAIRS,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1128/AAC.41.2.292
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A total of 1,537 clinical isolates of Haemophilus influenzae were recovered in 30 U.S. medical center laboratories between 1 November 1994 and 30 April 1995 and were characterized in a central laboratory with respect to serotype and beta-lactamase production and the in vitro activities of 15 oral antimicrobial agents, Overall, 36.4% of the isolates were found to produce beta-lactamase, The rank order of activity of sis cephalosporins on the basis of MICs was cefixime > cefpodoxime > eefuroxime > loracarbef greater than or equal to cefaclor > cefprozil. On the basis of current National Committee for Clinical Laboratory Standards (NCCLS) breakpoints, the overall percentages of isolates found to be resistant or intermediate to these agents were as follows: 0.1, 0.3, 6.4, 16.3, 18.3, and 29.8, respectively (National Committee for Clinical: Laboratory Standards, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. M7-A4, 1995), Azithromycin was, on a weight basis, the most potent of the macrolides tested in this study, followed by erythromycin and then clarithromycin, Azithromycin was typically fourfold more active than erythromycin, which was, in turn, slightly more active than clarithromycin, However, when compared an the basis of the frequency of resistance determined by using current NCCLS breakpoints, there was essentially no difference between azithromycin and clarithromycin, i.e., 0.5 and 1.9%, respectively (P = 0.086), Interpretive breakpoints for erythromycin MIC tests versus H. influenzae have not been developed, Resistance to other non-beta-lactam agents was variable, as follows: trimethoprim-sulfamethoxazole, 9.0%; chloramphenicol, 0.2%; tetracycline, 1.3%; and rifampin, 0.3%. Two conspicuous findings in this study were the identification of 39 strains of H. influenzae that were beta-lactamase negative but ampicillin intermediate or resistant (BLNAR) and, even more surprisingly, 17 beta-lactamase-positive isolates that were resistant to amoxicillin-clavulanate (BLPACR), Strains of H. influenzae in the first group have heretofore been very uncommon; organisms in the second group have not previously been described in the literature. The percentages of all study isolates comprised of BLNAR and BLPACR organisms were 2.5 and 1.1, respectively, Overall resistance to ampicillin was thus 38.9%, and that to amoxicillin-clavulanate was 4.5%.
引用
收藏
页码:292 / 297
页数:6
相关论文
共 29 条
[1]   IN-VITRO ACTIVITIES OF 12 ORALLY-ADMINISTERED ANTIMICROBIAL AGENTS AGAINST 4 SPECIES OF BACTERIAL RESPIRATORY PATHOGENS FROM US-MEDICAL-CENTERS IN 1992 AND 1993 [J].
BARRY, AL ;
PFALLER, MA ;
FUCHS, PC ;
PACKER, RR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (10) :2419-2425
[2]  
BELL SM, 1980, LANCET, V1, P279
[3]  
BLACK SB, 1992, PEDIATR INFECT DIS J, V11, P610
[4]  
Campos Joseph M., 1995, P556
[5]   MOLECULAR-BASIS OF THE NON-BETA-LACTAMASE-MEDIATED RESISTANCE TO BETA-LACTAM ANTIBIOTICS IN STRAINS OF HAEMOPHILUS-INFLUENZAE ISOLATED IN CANADA [J].
CLAIROUX, N ;
PICARD, M ;
BROCHU, A ;
ROUSSEAU, N ;
GOURDE, P ;
BEAUCHAMP, D ;
PARR, TR ;
BERGERON, MG ;
MALOUIN, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (07) :1504-1513
[6]  
DOERN G, 1995, AM J MED, V99
[7]  
DOERN G V, 1988, Clinical Microbiology Newsletter, V10, P185, DOI 10.1016/0196-4399(88)90017-7
[8]   PREVALENCE OF ANTIMICROBIAL RESISTANCE AMONG CLINICAL ISOLATES OF HAEMOPHILUS-INFLUENZAE - A COLLABORATIVE STUDY [J].
DOERN, GV ;
JORGENSEN, JH ;
THORNSBERRY, C ;
PRESTON, DA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1986, 4 (02) :95-107
[9]   NATIONAL COLLABORATIVE STUDY OF THE PREVALENCE OF ANTIMICROBIAL RESISTANCE AMONG CLINICAL ISOLATES OF HEMOPHILUS-INFLUENZAE [J].
DOERN, GV ;
JORGENSEN, JH ;
THORNSBERRY, C ;
PRESTON, DA ;
TUBERT, T ;
REDDING, JS ;
MAHER, LA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (02) :180-185
[10]   ENHANCEMENT OF THE INVITRO AND INVIVO ACTIVITIES OF CLARITHROMYCIN AGAINST HAEMOPHILUS-INFLUENZAE BY 14-HYDROXY-CLARITHROMYCIN, ITS MAJOR METABOLITE IN HUMANS [J].
HARDY, DJ ;
SWANSON, RN ;
RODE, RA ;
MARSH, K ;
SHIPKOWITZ, NL ;
CLEMENT, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (07) :1407-1413